Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni

Yazarlar: Begüm YURDAKÖK DİKMEN, Yağız PAT, Ergin DİLEKOZ, Gökçe Yağmur SUMMAK, Oguz KUL, Ayhan FİLAZİ

Konular:Veteriner Hekimlik

DOI:10.38137/vetfarmatoksbulten.769889

Anahtar Kelimeler:COVID-19,SARS-CoV-2,Pharmacotherapy,Drug repurposing

Özet: The novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been described as a global pandemic. Regardless the efforts all over the world, there is still no effective treatment or vaccine. Therefore, prevention, early virus detection and identification methods are crutially important for disease control. Treatment protocols are constantly updated with the results of controlled randomized clinical trials; however, the majority of research with a large number of patients are still not concluded. Individualized medicine is forefront since there is no uniform drug application in treatment as the drug efficacy and safety changes with respect to individual differences (such as changing phenotype, other chronic diseases). Treatment protocols are constantly being updated and drug research using artificial intelligence/in silico methods for new compounds and drug repurposing gained prominence. This review provides updated information on some of the agents used in the treatment of COVID-19.

---